Share-based Payment Arrangement, Expense of CHAMPIONS ONCOLOGY, INC. from 31 Jul 2011 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CHAMPIONS ONCOLOGY, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Jul 2011 to 31 Oct 2025.
  • CHAMPIONS ONCOLOGY, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Oct 2025 was $249,000, a 2667% increase year-over-year.
  • CHAMPIONS ONCOLOGY, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Oct 2025 was $844,000, a 7.2% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. annual Share-based Payment Arrangement, Expense for 2024 was $654,000, a 42% decline from 2023.
  • CHAMPIONS ONCOLOGY, INC. annual Share-based Payment Arrangement, Expense for 2023 was $1,118,000, a 29% increase from 2022.
  • CHAMPIONS ONCOLOGY, INC. annual Share-based Payment Arrangement, Expense for 2022 was $864,000, a 5.3% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $844,000 $249,000 +$240,000 +2667% 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 $604,000 $208,000 -$50,000 -19% 01 May 2025 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 $654,000 $131,000 -$132,000 -50% 01 Feb 2025 30 Apr 2025 10-K 23 Jul 2025 2025 FY
Q4 2024 $786,000 $256,000 -$123,000 -32% 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 $909,000 $9,000 -$44,000 -83% 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q2
Q2 2024 $953,000 $258,000 -$165,000 -39% 01 May 2024 31 Jul 2024 10-Q 15 Sep 2025 2026 Q1
Q1 2024 $1,118,000 $263,000 +$55,000 +26% 01 Feb 2024 30 Apr 2024 10-K 23 Jul 2025 2025 FY
Q4 2023 $1,063,000 $379,000 +$48,000 +15% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 $1,015,000 $53,000 -$66,000 -55% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q2
Q2 2023 $1,081,000 $423,000 +$217,000 +105% 01 May 2023 31 Jul 2023 10-Q 13 Sep 2024 2025 Q1
Q1 2023 $864,000 $208,000 +$20,000 +11% 01 Feb 2023 30 Apr 2023 10-K 19 Jul 2024 2024 FY
Q4 2022 $844,000 $331,000 +$21,000 +6.8% 01 Nov 2022 31 Jan 2023 10-Q 15 Mar 2024 2024 Q3
Q3 2022 $823,000 $119,000 -$15,000 -11% 01 Aug 2022 31 Oct 2022 10-Q 13 Dec 2023 2024 Q2
Q2 2022 $838,000 $206,000 -$74,000 -26% 01 May 2022 31 Jul 2022 10-Q 13 Sep 2023 2024 Q1
Q1 2022 $912,000 $188,000 +$27,000 +17% 01 Feb 2022 30 Apr 2022 10-K 24 Jul 2023 2023 FY
Q4 2021 $885,000 $310,000 +$78,000 +34% 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q3
Q3 2021 $807,000 $134,000 +$49,000 +58% 01 Aug 2021 31 Oct 2021 10-Q 13 Dec 2022 2023 Q2
Q2 2021 $758,000 $280,000 +$160,000 +133% 01 May 2021 31 Jul 2021 10-Q 12 Sep 2022 2023 Q1
Q1 2021 $598,000 $161,000 -$2,000 -1.2% 01 Feb 2021 30 Apr 2021 10-K 22 Jul 2022 2022 FY
Q4 2020 $600,000 $232,000 +$3,000 +1.3% 01 Nov 2020 31 Jan 2021 10-Q 15 Mar 2022 2022 Q3
Q3 2020 $597,000 $85,000 +$8,000 +10% 01 Aug 2020 31 Oct 2020 10-Q 13 Dec 2021 2022 Q2
Q2 2020 $589,000 $120,000 -$11,000 -8.4% 01 May 2020 31 Jul 2020 10-Q 13 Sep 2021 2022 Q1
Q1 2020 $600,000 $163,000 +$20,000 +14% 01 Feb 2020 30 Apr 2020 10-K 26 Jul 2021 2021 FY
Q4 2019 $580,000 $229,000 -$106,000 -32% 01 Nov 2019 31 Jan 2020 10-Q 15 Mar 2021 2021 Q3
Q3 2019 $686,000 $77,000 -$11,000 -12% 01 Aug 2019 31 Oct 2019 10-Q 14 Dec 2020 2021 Q2
Q2 2019 $697,000 $131,000 +$48,000 +58% 01 May 2019 31 Jul 2019 10-Q 14 Sep 2020 2021 Q1
Q1 2019 $649,000 $143,000 -$27,000 -16% 01 Feb 2019 30 Apr 2019 10-K 28 Jul 2020 2020 FY
Q4 2018 $676,000 $335,000 +$183,000 +120% 01 Nov 2018 31 Jan 2019 10-Q 16 Mar 2020 2020 Q3
Q3 2018 $493,000 $88,000 -$60,000 -41% 01 Aug 2018 31 Oct 2018 10-Q 16 Dec 2019 2020 Q2
Q2 2018 $553,000 $83,000 -$481,000 -85% 01 May 2018 31 Jul 2018 10-Q 16 Sep 2019 2020 Q1
Q1 2018 $1,034,000 $170,000 -$591,000 -78% 01 Feb 2018 30 Apr 2018 10-K 29 Jul 2019 2019 FY
Q4 2017 $1,625,000 $152,000 -$85,000 -36% 01 Nov 2017 31 Jan 2018 10-Q 18 Mar 2019 2019 Q3
Q3 2017 $1,710,000 $148,000 -$387,000 -72% 01 Aug 2017 31 Oct 2017 10-Q 17 Dec 2018 2019 Q2
Q2 2017 $2,097,000 $564,000 -$565,000 -50% 01 May 2017 31 Jul 2017 10-Q 14 Sep 2018 2019 Q1
Q1 2017 $2,662,000 $761,000 +$252,000 +50% 01 Feb 2017 30 Apr 2017 10-K 30 Jul 2018 2018 FY
Q4 2016 $2,410,000 $237,000 -$330,000 -58% 01 Nov 2016 31 Jan 2017 10-Q 19 Mar 2018 2018 Q3
Q3 2016 $2,740,000 $535,000 -$213,000 -28% 01 Aug 2016 31 Oct 2016 10-Q 15 Dec 2017 2018 Q2
Q2 2016 $2,953,000 $1,129,000 +$354,000 +46% 01 May 2016 31 Jul 2016 10-Q 14 Sep 2017 2018 Q1
Q1 2016 $2,599,000 $509,000 -$368,000 -42% 01 Feb 2016 30 Apr 2016 10-K 28 Jul 2017 2017 FY
Q4 2015 $2,967,000 $567,000 -$90,000 -14% 01 Nov 2015 31 Jan 2016 10-Q 17 Mar 2017 2017 Q3
Q3 2015 $3,057,000 $748,000 -$72,000 -8.8% 01 Aug 2015 31 Oct 2015 10-Q 14 Dec 2016 2017 Q2
Q2 2015 $3,129,000 $775,000 -$33,000 -4.1% 01 May 2015 31 Jul 2015 10-Q 14 Sep 2016 2017 Q1
Q1 2015 $3,162,000 $877,000 +$39,000 +4.7% 01 Feb 2015 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q4 2014 $3,123,000 $657,000 -$284,000 -30% 01 Nov 2014 31 Jan 2015 10-Q 16 Mar 2016 2016 Q3
Q3 2014 $3,407,000 $820,000 +$344,000 +72% 01 Aug 2014 31 Oct 2014 10-Q 15 Dec 2015 2016 Q2
Q2 2014 $3,063,000 $808,000 +$256,000 +46% 01 May 2014 31 Jul 2014 10-Q 11 Sep 2015 2016 Q1
Q1 2014 $2,807,000 $838,000 +$395,000 +89% 01 Feb 2014 30 Apr 2014 10-K 29 Jul 2015 2015 FY
Q4 2013 $2,412,000 $941,000 +$371,000 +65% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q3
Q3 2013 $2,041,000 $476,000 -$148,000 -24% 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2
Q2 2013 $2,189,000 $552,000 -$187,000 -25% 01 May 2013 31 Jul 2013 10-Q 12 Sep 2014 2015 Q1
Q1 2013 $2,376,000 $443,000 -$268,000 -38% 01 Feb 2013 30 Apr 2013 10-K 28 Jul 2014 2014 FY
Q4 2012 $2,644,000 $570,000 -$173,000 -23% 01 Nov 2012 31 Jan 2013 10-Q 14 Mar 2014 2014 Q3
Q3 2012 $2,817,000 $624,000 -$231,000 -27% 01 Aug 2012 31 Oct 2012 10-Q 13 Dec 2013 2014 Q2
Q2 2012 $3,048,000 $739,000 -$275,000 -27% 01 May 2012 31 Jul 2012 10-Q 13 Sep 2013 2014 Q1
Q1 2012 $3,323,000 $711,000 01 Feb 2012 30 Apr 2012 10-K 26 Jul 2013 2013 FY
Q4 2011 $743,000 01 Nov 2011 31 Jan 2012 10-Q 13 Mar 2013 2013 Q3
Q3 2011 $855,000 01 Aug 2011 31 Oct 2011 10-Q 13 Dec 2012 2013 Q2
Q2 2011 $1,014,000 01 May 2011 31 Jul 2011 10-Q 12 Sep 2012 2013 Q1

CHAMPIONS ONCOLOGY, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $654,000 -$464,000 -42% 01 May 2024 30 Apr 2025 10-K 23 Jul 2025 2025 FY
2023 $1,118,000 +$254,000 +29% 01 May 2023 30 Apr 2024 10-K 23 Jul 2025 2025 FY
2022 $864,000 -$48,000 -5.3% 01 May 2022 30 Apr 2023 10-K 19 Jul 2024 2024 FY
2021 $912,000 +$314,000 +53% 01 May 2021 30 Apr 2022 10-K 24 Jul 2023 2023 FY
2020 $598,000 -$2,000 -0.33% 01 May 2020 30 Apr 2021 10-K 22 Jul 2022 2022 FY
2019 $600,000 -$49,000 -7.6% 01 May 2019 30 Apr 2020 10-K 26 Jul 2021 2021 FY
2018 $649,000 -$385,000 -37% 01 May 2018 30 Apr 2019 10-K 28 Jul 2020 2020 FY
2017 $1,034,000 -$1,628,000 -61% 01 May 2017 30 Apr 2018 10-K 29 Jul 2019 2019 FY
2016 $2,662,000 +$63,000 +2.4% 01 May 2016 30 Apr 2017 10-K 30 Jul 2018 2018 FY
2015 $2,599,000 -$563,000 -18% 01 May 2015 30 Apr 2016 10-K 28 Jul 2017 2017 FY
2014 $3,162,000 +$355,000 +13% 01 May 2014 30 Apr 2015 10-K 29 Jul 2016 2016 FY
2013 $2,807,000 +$431,000 +18% 01 May 2013 30 Apr 2014 10-K 29 Jul 2015 2015 FY
2012 $2,376,000 -$947,000 -28% 01 May 2012 30 Apr 2013 10-K 28 Jul 2014 2014 FY
2011 $3,323,000 01 May 2011 30 Apr 2012 10-K 26 Jul 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.